Ken Griffin Neuro Sense Therapeutics Ltd. Call Options Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
9Shares Held
245KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$82,6710.01% of portfolio
-
Xtx Topco LTD London, X046KShares$47,8350.0% of portfolio
-
Meitav Dash Investments LTD40KShares$41,6000.0% of portfolio
-
Stratos Wealth Partners, Ltd.20KShares$20,8000.0% of portfolio
-
Commonwealth Equity Services, LLC12.6KShares$13,1300.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $12.1M